Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1987 Sep;62(9):938–940. doi: 10.1136/adc.62.9.938

Acarboxyprothrombin concentration [corrected] after oral prophylactic vitamin K.

R von Kries 1, S Kreppel 1, A Becker 1, R Tangermann 1, U Göbel 1
PMCID: PMC1778562  PMID: 3435609

Abstract

The effect of prophylaxis with oral vitamin K (1 mg vitamin K1 given with the first feed) on the rate of detection of acarboxyprothrombin (PIVKA II) and factor II clotting concentration [corrected] were analysed. Introducing such prophylaxis reduced the rates of detection of PIVKA II concentration [corrected] on day 5 from 48% to zero. None of the babies given prophylaxis had factor II clotting concentration [corrected] below 40%, compared with 34 of 95 babies not given prophylaxis. This study has important implications in the prophylaxis of both classical and late onset haemorrhagic disease of the newborn.

Full text

PDF
938

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Choonara I. A., Park B. K. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child. 1985 Dec;60(12):1203–1204. doi: 10.1136/adc.60.12.1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Garrow D., Chisholm M., Radford M. Vitamin K and Thrombotest values in full term infants. Arch Dis Child. 1986 Apr;61(4):349–351. doi: 10.1136/adc.61.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. McNinch A. W., Upton C., Samuels M., Shearer M. J., McCarthy P., Tripp J. H., L'E Orme R. Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child. 1985 Sep;60(9):814–818. doi: 10.1136/adc.60.9.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Motohara K., Endo F., Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet. 1985 Aug 3;2(8449):242–244. doi: 10.1016/s0140-6736(85)90291-0. [DOI] [PubMed] [Google Scholar]
  5. O'Connor M. E., Addiego J. E., Jr Use of oral vitamin K1 to prevent hemorrhagic disease of the newborn infant. J Pediatr. 1986 Apr;108(4):616–619. doi: 10.1016/s0022-3476(86)80851-4. [DOI] [PubMed] [Google Scholar]
  6. Petrich C., Pothmann R., Döhmen A., Voss H., Göbel U. A haematocrit corrected micro determination of the P&P-test and blood clotting factors in capillary blood. Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):510–518. [PubMed] [Google Scholar]
  7. WEFRING K. W. Hemorrhage in the newborn and vitamin K prophylaxis. J Pediatr. 1962 Nov;61:686–692. doi: 10.1016/s0022-3476(62)80339-4. [DOI] [PubMed] [Google Scholar]
  8. von Kries R., Reifenhäuser A., Göbel U., McCarthy P., Shearer M. J., Barkhan P. Late onset haemorrhagic disease of newborn with temporary malabsorption of vitamin K1. Lancet. 1985 May 4;1(8436):1035–1035. doi: 10.1016/s0140-6736(85)91628-9. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES